References
- T.NeogiClinical practice: goutN Engl J Med3642011443 52
- R.TerkeltaubUpdate on gout: new therapeutic strategies and optionsNat Rev Rheumatol6201030 8
- N.DalbethO.AatiA.GaoAssessment of tophus size: a comparison between physical measurement methods and dual-energy computed tomography scanningJ Clin Rheumatol18201223 7
- N.DalbethB.ClarkK.GregoryMechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomographyAnn Rheum Dis6820091290 5
- M.A.DesaiJ.J.PetersonH.W.GarnerClinical utility of dual-energy CT for evaluation of tophaceous goutRadiographics3120111365 75
- Y.ZhuB.J.PandyaH.K.ChoiPrevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008Arthritis Rheum6320113136 41
- A.S.Al-ArfajHyperuricemia in Saudi ArabiaRheumatol Int202200061 4
- L.AnnemansE.SpaepenM.GaskinGout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005Ann Rheum Dis672008960966
- P.ReberX.CrevoisierB.NoesbergerUnusual localisation of tophaceous gout. A report of four cases and review of the literatureArch Orthop Trauma Surg11551996297299
- D.SchapiraS.StahlO.B.IzhakChronic tophaceous gouty arthritis mimicking rheumatoid arthritisSemin Arthritis Rheum29119995663
- C.P.ShoganC.L.FolioTophaceous gout and rheumatoid arthritis awarenessJ Am Osteopath Assoc10872008352 3
- Medsafe Pharmacovigilance Team. Colchicine: lower doses for greater safety Publishing; 2005. http://www.medsafe.govt.nz/profs/puarticles/colchdose.htm (Accessed November 2005).
- G.NukiColchicine: its mechanism of action and efficacy in crystal-induced inflammationCurr Rheumatol Rep102008218227
- D.KhannaP.P.KhannaJ.D.Fitzgerald2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and anti-inflammatory prophylaxis of acute gouty arthritisArthritis Care Res641020121447 61
- D.KhannaJ.D.FitzgeraldP.P.Khanna2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic non pharmacologic and pharmacologic therapeutic approaches to hyperuricemiaArthritis Care Res641020121431 46
- J.ChaoR.TerkelatubA critical reappraisal of Allopurinol dosing, safety and efficacy for hyperuricemia in goutCurr Rheumatol Rep112009135140
- M.K.ReindersC.HaagsmaT.L.JansenArandomised controlled trial on the efficacy and tolerability with dose escalation of Allopurinol 300–600 mg/day versus benzobromaron 100–200 mg/day in patients with goutAnn Rheum Dis6862009892897
- B.ArrolM.BennettN.DalbethMore Allopurinol is needed to get gout patients<0.36 mmol/l: a gout audit in the form of a before-after trial.J prim Health Care.142009315318
- H.HarrisConsultant Rheumatologist Review approved on behalf of NHS Fife by the Fife Area Drugs & Therapeutics CommitteeBPJ3720113440